GSK plc (GSK) Q2 2023 Earnings Call Transcript

GSK plc (NYSE:GSK) Q2 2023 Earnings Conference Call July 26, 2023 7:00 AM ET

Company Participants

Nick Stone - Senior Vice President, Head, Investor Relations
Emma Walmsley - Chief Executive Officer
Tony Wood - Chief Scientific Officer
Luke Miels - Chief Commercial Officer
Deborah Waterhouse - Chief Executive Officer, ViiV Healthcare & President, Global Health
Julie Brown - Chief Financial Officer

Conference Call Participants

James Gordon - JPMorgan
Jo Walton - Credit Suisse
James Quigley - Morgan Stanley
Emily Field - Barclays
Peter Welford - Jeffries
Eric Le Berrigaud - Stifel
Michael Leuchten - UBS
Graham Parry - Bank of America
Rajesh Kumar - HSBC
Richard Parkes - BNP Paribas
Andrew Baum - Citi
Kerry Holford - Berenberg
Simon Baker - Redburn
Emmanuel Papadakis - Deutsche Bank
Steve Scala - Cowen

Nick Stone

Hello, everyone. Welcome to our Half Year End Q2 2023 conference call webcast investors and analysts. Presentation was sent to our distribution list by e-mail, and you can also find it on gsk.com. Please turn to Slide 2.

This is the usual Safe Harbor statement. We will comment on our performance using constant exchange rates, or CER, unless stated otherwise. As a reminder, following the Consumer Healthcare demerger in 2022 to form Haleon. We're presenting the performance and growth of continuing operations for GSK.

Please turn to Slide 3. Today's call will last approximately 1 hour and management presentation will take 35 minutes with the remaining time for your questions, [Operator Instructions].

Our speakers today are Emma Walmsley, Tony Wood, Luke Miels, Deborah Waterhouse, and Julie Brown with David Redfern joining the rest of the team for Q&A portion of the call.

Turning to Slide 4, I will now hand the call over to Emma.

Emma Walmsley

Thanks, Nick, and a very warm welcome to everyone joining us today. I'm